A new approach to support specialist prescribing of bDMARDs
Arthritis Australia is part of an eight-member Consortium led by NPS MedicineWise, which is the successful recipient of the ‘Value in Prescribing biological disease-modifying anti-rheumatic drugs (bDMARDs)’ government grant.
The grant will fund a project to improve the use of bDMARDs to ensure the best health and economic outcomes from investment in these therapies.
NPS MedicineWise media release – bDMARDS September 2019 (002)
Discover more...
-
New Website Empowers Australians with Osteoarthritis
Press Release [Sydney, Australia] Australians living with osteoarthritis now have a powerful new resource at their fingertips with the launch of MyOA/ MyJointPain (https://myoa.org.au/), a...
-
Arthritis Australia | 2024 year in review
In 2024, Arthritis Australia made significant strides in advocating for better care for the 7+ million Australians living with arthritis and musculoskeletal conditions. Parliamentary Summit...
-
Gout Awareness Day | May 22, 2025 : Busting Myths, Ending Stigma, and Empowering Australians to Take Control
Gout Awareness Day | May 22, 2025 : Busting Myths, Ending Stigma, and Empowering Australians to Take ControlSydney, Australia – This Gout Awareness Day, Arthritis...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
